The most common adverse reactions observed in the clinical trials of Bactrim include neutropenia, thrombocytopenia, and anemia.
In the BACTrim trials, 7/1787 and 8/1787, the neutropenic patients experienced a greater proportion of side effects compared to patients who received placebo (p<0.001). The neutropenic patients treated with Bactrim had a mean reduction in platelet count from 6.3 to 3.8 x 10(6)/L vs. 3.2 to 2.8 x 10(6)/L (p=0.001). In addition, the neutropenic patients treated with Bactrim had a reduction in serum bilirubin from 2.3 to 0.9 mg/dL, compared to baseline (p=0.038). The neutropenic patients treated with Bactrim had a mean reduction in serum creatinine from 3.0 to 1.7 mg/dL, compared to baseline (p=0.003).
The incidence of thrombocytopenia, anemia, and neutropenia in the BACTrim group was significantly lower than in the placebo group, and the neutropenia group was less likely to have any of the above adverse reactions.
The incidence of anemia was not significantly different in the BACTrim group and the placebo group.
The incidence of thrombocytopenia and anemia was observed to be highest in patients with a history of myocardial infarction (MI). The incidence of thrombocytopenia was highest in patients with a myocardial infarction history (2.3 to 3.2% versus 0.8% in the BACTrim group, p<0.001).
In the BACTrim-MIock trial, the incidence of thrombocytopenia in patients with a myocardial infarction history was 2.4% vs. 1.4%, and the incidence of anemia was 1.7% vs. 0.6%, respectively.
Patients with a myocardial infarction history had higher rates of thrombocytopenia (3.0% vs. 2.5%) compared to patients with a history of MI (2.0% vs. 1.6%). Patients with a myocardial infarction history had significantly higher rates of anemia (6.3% vs. 2.3%).
The rates of thrombocytopenia in the BACTrim-MIock group were higher than in the placebo group at 3.3% (0.9% vs. 1.2%), 3.0% (0.9% vs. 0.8%), and 3.3% (0.9% vs. 0.8%) but not at 2.4% (0.9% vs. 0.2%) or 3.0% (0.9% vs. 0.2%) (p=0.051). The incidence of thrombocytopenia was significantly higher in patients with a myocardial infarction history (7.6% vs. 3.1%), 4.2% (0.9% vs. 0.4%), and 4.3% (0.9% vs. 0.3%) (p=0.005). The incidence of thrombocytopenia was also significantly higher in patients with a myocardial infarction history (3.1% vs. 0.4%), 4.3% (0.9% vs. 0.3%), and 4.3% (0.9% vs. 0.3%) (p=0.007). The incidence of thrombocytopenia was significantly higher in patients with a myocardial infarction history (3.1% vs. 0.3%), 4.2% (0.9% vs. 0.3%) (p=0.006). The rates of thrombocytopenia were also significantly higher in patients with a myocardial infarction history (3.1% vs. 0.4%), 4.2% (0.9% vs. 0.3%) (p=0.003).
The incidence of anemia in the BACTrim-MIock trial was 1.3% (0.8% vs. 0.3%) and 0.6% (0.8% vs. 0.3%) at 2.4%, 3.0% (0.
Medically reviewed by Jessica Swirble, PharmDLast updated on April 18, 2025
Drug Information| | |
Bactrim DS is an oral antibiotic used to treat and gonorrhea. It is used to treat gonorrhea when prescribed by a doctor.
Trimethoprim DS-500 is an antibacterial (oral medication) used to treat gonorrhea. It is used to treat acute gonorrhea, uncomplicated gonorrhea, and gonorrhea that does not respond to other antibacterial drugs. Gonorrhea that is treated with trimethoprim-resistant isol of gonorrhea is judged to be treatable.
Trimethoprim DS-500 is a combination antibiotic used to treat complicated gonorrhea and acute uncomplicated gonorrhea. Gonorrhea that is treated with trimethoprim-resistant gonorrhea is judged to be treatable.
Gonorrhea that is treated with gonorrhea-related antibacterial therapy is not defined by the World Health Organization as resistant strains of gonorrhea that are susceptible to trimethoprim-resistant strains of gonorrhea that are susceptible to other antibacterial drugs. These isolates of gonorrhea that are susceptible to trimethoprim-resistant gonorrhea are not treatable.
Trimethoprim-resistant gonorrhea that is treated with trimethoprim-resistant isol of gonorrhea-associated bacterial infections is judged to be treatable.
Gonorrhea that is treated with trimethoprim-resistant gonorrhea-related antibacterial therapy is not defined by the World Health Organization as resistant strains of gonorrhea that are susceptible to other antibacterial drugs. These isolates of gonorrhea- related gonorrhea-infectious strains of the bacterial group that are resistant to trimethoprim-resistant strains of gonorrhea-related antibacterial therapy-ydia (Gonorrhea that is treated with gonorrhea-related antibacterial therapy-ydia) (group G) are not treatable.
Trimethoprim DS-500 is a combination antibiotic used to treat gonorrhea and acute uncomplicated gonorrhea. Gonorrhea that is treated with trimethoprim-resistant gonorrhea-related gonorrhea-related antibacterial therapy is judged to be treatable.
Trimethoprim DS-500 is a single-dose combination antibiotic that treats gonorrhea and acute uncomplicated gonorrhea. Gonorrhea that is treated with trimethoprim-resistant gonorrhea-resistance isolates of gonorrhea-related antibacterial therapy-ydia (Group G) are not treatable.
Gonorrhea that is treated with gonorrhea-related antibacterial therapy is judged to be treatable.
Trimethoprim DS-500 is a second-line treatment for acute uncomplicated gonorrhea and uncomplicated gonorrhea that is not treatable, and it is not known whether it is appropriate or only considered treatment of gonorrhea-related antibacterial drugs.
Gonorrhea that is treated with gonorrhea-related antibacterial therapy-ydia (Group G) is not defined by the World Health Organization as resistant strains of gonorrhea-resisting isolates of gonorrhea-related antibacterial therapy-ydia. These isolates of gonorrhea- related gonorrhea-infectious strains of the bacterial group that are resistant to trimethoprim-resistant gonorrhea-related antibacterial therapy-ydia are not treatable.
Trimethoprim DS-500 is a third-line treatment for uncomplicated gonorrhea and uncomplicated acute uncomplicated gonorrhea that is not treatable.
Trimethoprim DS-500 is a single-dose combination antibiotic that treats gonorrhea and uncomplicated gonorrhea.
Aminolytics for Bacterial Infections
Bactrim is an effective antibiotic that effectively treats bacterial infections, including respiratory tract infections. It works by disrupting the cell wall and reducing the bacteria's growth. However, it can also cause some side effects such as nausea, diarrhea, and skin rashes. This medication is available in a variety of forms, including tablets, oral suspensions, and oral suspension. Bactrim works by inhibiting bacterial growth and preventing further infection. It is commonly used in children and adults to treat severe respiratory tract infections, such as bronchitis and pneumonia, and to prevent the spread of bacterial infections in people with compromised immune systems. Bactrim is typically prescribed as a once-daily oral tablet, which should be swallowed whole with a small glass of water. It can also be taken with or without food, but it is important to follow the directions carefully. Patients may experience side effects such as nausea, vomiting, or skin rashes that are more likely to occur with higher doses. Bactrim is effective against a wide range of bacteria, including those that cause infections. It is important to use Bactrim as prescribed, as it can interact with other medications or have other side effects. Patients should also be cautious of the risk of adverse reactions when taking this medication, as they may interact with other medications. Bactrim is available in various strengths, including two milligrams, three milligrams, and six milligrams. It is important to follow the prescribed dosage and to discuss any concerns with a healthcare provider.
Bacterial Infections Treated with Bactrim
Bactrim is an antibiotic that can be used to treat bacterial infections, including pneumonia, ear infections, bronchitis, and sinus infections. It is effective against a wide range of bacteria, including those that cause infections. It is available in various forms, including tablets, oral suspensions, and oral suspensions. Bactrim is usually prescribed in doses of 2 milligrams or 1 milligram taken every 4 to 6 hours. It is also effective against a wide range of bacteria, including those that cause infections. Bactrim can be taken with or without food, but it is important to follow the directions carefully. Patients should be cautious of the risk of side effects when taking this medication, as they may interact with other medications or have other health issues. Bactrim is generally well-tolerated, but it can cause some side effects such as nausea, diarrhea, and skin rashes. It is important to take Bactrim as prescribed, but it may not be effective for all patients. Some patients may experience mild gastrointestinal side effects such as nausea or diarrhea, while others may experience more severe symptoms such as liver or kidney problems. In rare cases, Bactrim may cause more serious side effects such as liver or heart problems, seizures, or sudden death.
Bactrim DS is an antibiotic used to treat infections caused by susceptible strains of bacteria. It may also be used to treat other bacterial infections, such as urinary tract infections, bronchitis, infections of the skin and soft tissue, infections of the skin caused by organisms sensitive to it (eg, anthrax), skin infections (eg, rosacea), and other infections. Prescribed for Bacterial Infections.
Medically reviewed by.Yes. In clinical trials, Bactrim DS caused significant improvements in patients' symptoms such as body aches, a weakened immune system, and frequent minor infections at doses as low as 25 mg/day. Bactrim DS was also generally well-tolerated, with most patients reporting no adverse effects. Bactrim DS is not recommended for use in children or teenagers under 18 years of age because it can cause permanent discoloration of the teeth and hearing loss. Prescribed for Blood Clostridium difficile.
Bactrim DS is also used to treat certain infections of the stomach (eg, enteritis) caused by susceptible organisms called Helicobacter pylori (H. pylori) and to prevent stomach ulcers caused by organisms called Morganella morganii (a type of bacteria that is resistant to many medications). Bactrim DS is not FDA approved for use in children under 18 years of age.
Prescription onlyBactrim DS (Bactrim) may also be used for purposes not listed in this medication guide.
Bactrim DS is a prescription medication. It is important to follow the instructions given by your doctor to achieve the best results with the prescribed dose. If you have any questions about why this medication is prescribed, talk to your doctor.
Tell your doctor if your condition does not improve or if it worsens.
Consult your doctor before taking Bactrim DS if you have any medical conditions.
Your doctor will determine if Bactrim DS is right for you depending on your medical condition and how you respond to the medication. Be sure to tell your doctor about all the prescription medications you are taking, including vitamins, supplements, and herbal products. Be sure to tell your doctor what all the drugs you are currently taking are.
Tell your doctor if your condition lasts or gets worse.
Tell your doctor if your condition does not improve or if if if other therapies tried were ineffective.
Your doctor will probably tell you not to take Bactrim DS unless you have been prescribed it by a health care professional. In these cases, Bactrim DS should only be used as prescribed and under medical supervision. Do not use Bactrim DS more often than directed.
Bactrim DS should be taken with food to avoid stomach upset. If you miss a dose, take it as soon as possible and continue with your regular schedule. If it is almost time for your next dose, skip the missed dose and continue with your regular dosing schedule. Do not take a double dose to make up for a missed dose.
Bactrim is the brand name for a penicillin antibiotic called sulfamethoxazole, which is sold under the brand names Trimethoprim and Bactrim. In the UK, it is known by the generic name Bactrim. Bactrim is available in a variety of strengths, including trimethoprim 500mg, Bactrim DS 500mg, Bactrim DS 30mg, and Bactrim DS 30mg.
When you take Bactrim, your body starts working. The first signs of infection in the body start happening in the first few days of taking the antibiotic. The bacteria that you get from your body starts to grow as the antibiotic works.
If you have trouble getting an infection from a bacteria called a bacteria called a Klebsiella. This is a common bacteria that is known to be sensitive to trimethoprim and Bactrim, as well as to Bactrim. You will start to get a small number of bacteria in your body in the first week or two of taking the medicine. Then, in the fourth week, there is a small number of bacteria in your body that are resistant to the drug. This is a common side effect of Bactrim that can happen when you take the drug in the first place. In the meantime, the bacteria in the body that are sensitive to Bactrim are becoming resistant to the antibiotic. This means that your body can no longer get the antibiotic that you need.
When you take Bactrim, the body is no longer able to fight the infection. The bacteria that are resistant to the antibiotic will eventually die. As a result, your body gets weaker. The infection starts to heal.
In addition to the above symptoms, when you take Bactrim, your body does not fight the infection properly. When it comes to how it works, you will know the first signs of infection in the body are not necessarily bad. They are not always the best. They are always the best sign of a bacterial infection. Your body may not get rid of the infection, but it will go away.
You can get a small number of bacteria in your body in the first week or two of taking the medicine. In the meantime, the bacteria in the body that are resistant to the drug are becoming resistant to the antibiotic.
Stade de France Pharmacy